NEWARK, Calif., Jan. 9, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem cell-based research and drug discovery, announced today that Martin McGlynn, President and CEO, will present a business update at the Biotech Showcase 2012 to be held January 9-11 at the Parc 55 Wyndham Hotel in San Francisco, California. Mr. McGlynn is scheduled to speak on Tuesday, January 10, at 1:45 pm PST.
